These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 13871268)

  • 21. [The monoamine oxidase inhibitor serine-isopropylhydrazide in clinical psychiatry].
    VOELKEL A
    Klin Wochenschr; 1959 Jun; 37(11):613-4. PubMed ID: 13673533
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of iproniazid with other amine oxidase inhibitors, including W-1544, JB-516, RO 4-1018, and RO 5-0700.
    BAILEY SD; BUCCI L; GOSLINE E; KLINE NS; PARK IH; ROCHLIN D; SAUNDERS JC; VAISBERG M
    Ann N Y Acad Sci; 1959 Sep; 80():652-68. PubMed ID: 13795859
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical toxicity studies of a monoamine oxidase inhibitor.
    GREENBLATT IJ; KAHN A
    Ann N Y Acad Sci; 1959 Sep; 80():947-59. PubMed ID: 13851575
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of depressive states with marplan.
    OLTMAN JE; FRIEDMAN S
    Am J Psychiatry; 1960 Mar; 116():848-9. PubMed ID: 14428837
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experience in the treatment of mental depression with and inhibitor of cerebral monoamine oxidase: beta-phenyl-isopropyl hydrazine].
    CASTELLUCCIO R
    Sem Med; 1960 May; 116():867-80. PubMed ID: 13808292
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidase inhibitors. II. Some amino and dialkylaminobenzyl hydrazines and their acyl derivatives.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1961 Mar; 3():241-52. PubMed ID: 13896916
    [No Abstract]   [Full Text] [Related]  

  • 27. Monoamine oxidase inhibitors. I. 1-Alkyl and 1-aralkyl-2-(picolinoyl and 5-methyl-3-isoxazolyl-carbonyl)hydrazines.
    GARDNER TS; WENIS E; LEE J
    J Med Pharm Chem; 1960 Apr; 2():133-45. PubMed ID: 13826540
    [No Abstract]   [Full Text] [Related]  

  • 28. [Experiences in the treatment of depressive states with 1-seryl-2-isopropylhydrazine].
    HEINRICH K
    Psychiatr Neurol (Basel); 1960 Jul; 140():119-25. PubMed ID: 13712966
    [No Abstract]   [Full Text] [Related]  

  • 29. The pharmacological evaluation of monoamine oxidase inhibitors.
    LESSIN AW
    Biochem Pharmacol; 1959 Nov; 2():290-8. PubMed ID: 14416030
    [No Abstract]   [Full Text] [Related]  

  • 30. Significance of monoamine oxidase inhibition for the pharmacological and clinical effects of hydrazine derivatives.
    PLETSCHER A
    Ann N Y Acad Sci; 1959 Sep; 80():1039-45. PubMed ID: 14433482
    [No Abstract]   [Full Text] [Related]  

  • 31. A non-hydrazine monoamine oxidase inhibitor with antihypertensive properties.
    HORWITZ D; SJOERDSMA A
    Proc Soc Exp Biol Med; 1961 Jan; 106():118-20. PubMed ID: 13716049
    [No Abstract]   [Full Text] [Related]  

  • 32. Histochemical demonstration in rat of monoamine oxidase inhibition of beta-phenyl-isopropyl hydrazine.
    MUSTAKALLIO KK; LEVONEN E; RAEKALLIO J
    Science; 1961 Aug; 134(3475):344. PubMed ID: 13727138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticonvulsant properties of monoamine oxidase inhibitors.
    PROCKOP DJ; SHORE PA; BRODIE BB
    Ann N Y Acad Sci; 1959 Sep; 80():643-51. PubMed ID: 14434994
    [No Abstract]   [Full Text] [Related]  

  • 34. A new and safer monoamine oxidase inhibitor.
    ROBIE TR
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239
    [No Abstract]   [Full Text] [Related]  

  • 35. An unusual reaction to an MAO inhibitor.
    TUPIN J
    Dis Nerv Syst; 1961 Nov; 22():641-4. PubMed ID: 13923104
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the preparation Ro 4-1038 (monoamine oxidase inhibitor)].
    REITER PJ
    Psychiatr Neurol (Basel); 1960 Jul; 140():143-7. PubMed ID: 13740696
    [No Abstract]   [Full Text] [Related]  

  • 37. Reversal of the reserpine-induced depletion of brain serotonin by a monoamine oxidase inhibitor.
    CANAL N; MAFFEI-FACCIOLI A
    J Neurochem; 1959 Dec; 5():99-100. PubMed ID: 13807360
    [No Abstract]   [Full Text] [Related]  

  • 38. Stupor from dextroamphetamineamobarbital and monoamine oxidase inhibitor, phenelzine.
    ROECKER RD; LANE M
    J Med Soc N J; 1961 Feb; 58():47-9. PubMed ID: 13742660
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 40. Theoretic background of therapy with monoamine oxidase inhibitors in cardiology.
    ZBINDEN G
    Am J Cardiol; 1960 Dec; 6():1121-4. PubMed ID: 13788034
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.